Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease who are eligible to receive the drug.

A new drug tested in a phase 3 trial showed significant improvement in patients with treatment-resistant ovarian cancer.

Post-traumatic osteoarthritis (PTOA) is a condition that affects joints after an injury. Current treatments focus on ...

A team of pharmaceutical researchers at Novartis Biomedical Research, working with an international team of associates, has ...

“Every person working on it was let go,” Hoenig said, noting that the data collection is mandated by Congress. The office is ...

Not long ago, someone seeking withdrawal management at Fora Health risked being turned away due to lack of beds. Now, half ...

Staff didn’t realize 30-year-old Justin Cartwright died until the next day, according to his parents’ lawsuit.

Hospitals routinely report parents to child welfare authorities based on error-prone drug tests. Some hospitals are changing ...

Fentanyl is a dangerous and deadly drug. The Drug Enforcement Agency (DEA) reported that it is 100 times more potent than ...

A team of scientists from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has identified ...

The FDA on Thursday gave the green light to Uplizna in IgG4-related disease, making it the first and only approved treatment ...